Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
The product will be manufactured at Lupin's facility in Nagpur, India.
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
Dasatinib Tablet is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs
The drug will be available in 600 hospitals and 105 DTPs
Subscribe To Our Newsletter & Stay Updated
